Danimer Scientific Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On October 23, 2024, Danimer Scientific, Inc. (the “Company”) held a Special Meeting of Stockholders (“Special Meeting”). Of the 120,771,640 shares of the Company’s Class A common stock, par value $0.0001 per share (“Common Stock”) outstanding and entitled to vote at the Annual Meeting, 68,098,245 shares of Common Stock were present in person or by proxy, representing approximately 56% of the Company’s shares of Common Stock entitled to vote at the Special Meeting.
At the Special Meeting, the Company’s stockholders approved the following proposal:
Proposal 1 – To approve an amendment and restatement of the Company’s Fifth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of all outstanding shares of Common Stock into a lesser number of shares of Common Stock at a ratio in the range of 1-for-20 to 1-for-40 (“Range”) with the ratio within such Range to be determined at the discretion of the Board of Directors without further approval or authorization of the Company’s stockholders and included in a public announcement and such amended and restated certificate of incorporation.
The voting results are set forth below:
Votes For |
Votes Against |
Votes Abstained |
63,069,760 |
4,414,588 |
613,897 |
Item 9.01 Financial Statements and Exhibits.
d) Exhibits.
|
|
|
Exhibit No. |
|
Description |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
Danimer Scientific, Inc |
|
|
|
|
Date: |
October 23, 2024 |
By: |
/s/ Stephen A. Martin |
|
|
|
Stephen A. Martin |